Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trial.

医学 球囊扩张 支架 狭窄 外科 克罗恩病 气球 随机对照试验
作者
Carme Loras,Xavier Andújar,Joan B Gornals,Vicente Sanchiz,Enric Brullet,Beatriz Sicilia,Maria Dolores Martín-Arranz,Antonio Naranjo,Jesús Barrio,Carmen Dueñas,José Ramón Foruny,David Busquets,David Monfort,Juan Ramón Pineda,Ferran González-Huix,Francisco Pérez-Roldán,Vicente Pons,Begoña González,José Reyes Moreno,Empar Sainz,Jordi Guardiola,Marta Maia Bosca-Watts,Fernando Fernández-Bañares,Vicenç Mayor,Maria Esteve
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier BV]
卷期号:7 (4): 332-341 被引量:5
标识
DOI:10.1016/s2468-1253(21)00386-1
摘要

Endoscopic balloon dilation (EBD) is the established endoscopic treatment for short strictures in Crohn's disease. Fully covered self-expandable metal stents (FCSEMS) have been used for endoscopic treatment of patients for whom EBD was unsuccessful. We aimed to determine the efficacy and safety of the two endoscopic treatments in patients with Crohn's disease with stenosis and compare the mean cost of both treatments.This multicentre, open-label, randomised trial was done in 19 tertiary and secondary hospitals in Spain. Patients with Crohn's disease with obstructive symptoms and predominantly fibrotic strictures of less than 10 cm in length were eligible for inclusion. We excluded patients with stenosis treated with SEMS or EBD in the previous year and stenosis not accessible to a colonoscope. Patients were randomly assigned (1:1) to receive either EBD (EBD group) or FCSEMS (FCSEMS group) using a digital en-block randomisation system (block size of four). In the EBD group, dilation was done with a CRE Boston Scientific (Marlborough, MA, USA) pneumatic balloon with the diameter set at the discretion of the endoscopist; a maximum of two sessions of dilation were allowed with a minimum interval of 15-30 days between them. In the FCSEMS group, a 20 mm diameter Taewoong (Gimpo-si, South Korea) fully covered metal stent was placed; stent length was set at the discretion of the endoscopist. The primary outcome was to assess the efficacy of the endoscopic treatment, defined by the proportion of patients free of a new therapeutic intervention (EBD, FCSEMS, or surgery) due to symptomatic recurrence at 1 year of follow-up. Patients were analysed according to the intention-to-treat principle. Adverse events were recorded for all the patients; events were considered associated to be with the procedure when a causal association was possible, probable, or definite. This trial is registered with ClinicalTrials.gov, NCT02395354.From Aug 28, 2013, to Oct 9, 2017, we assessed the eligibility of 99 patients, of whom 19 (19%) patients were excluded. Thus, 80 (81%) patients were randomly assigned to treatment: 39 (49%) patients to the FCSEMS group and 41 (51%) patients to the EBD group. 33 (80%) of 41 patients in the EBD group and 20 (51%) of 39 patients in the FCSEMS group were free of a new therapeutic intervention at 1 year (odds ratio [OR] 3·9 [95% CI 1·4-10·6]; p=0·0061). Two (3%) of 80 patients had severe adverse events (one [2%] patient in the EBD group and one [3%] patient in the FCSEMS group); both patients had perforations.EBD is more effective than FCSEMS for Crohn's disease strictures, with a good safety profile for both treatments.Spanish National Institute of Health, Foundation of Spanish Society of Digestive Endoscopy, Catalan Society of Gastroenterology, and Taweoong.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
司徒不二完成签到,获得积分0
刚刚
ZoeyJ完成签到 ,获得积分10
1秒前
CC完成签到 ,获得积分10
1秒前
2秒前
zzg完成签到,获得积分10
4秒前
我本人lrx完成签到 ,获得积分10
4秒前
朝阳满意发布了新的文献求助10
4秒前
purplish发布了新的文献求助10
5秒前
快乐小白菜完成签到,获得积分10
5秒前
6秒前
廖喜林完成签到,获得积分10
6秒前
Cakoibao的应助被开心德地采纳,获得10
7秒前
komorebi完成签到 ,获得积分10
7秒前
万能图书馆的应助被一一采纳,获得10
7秒前
温柔梦易完成签到,获得积分10
8秒前
zhangliuyun完成签到,获得积分10
8秒前
优美甜瓜完成签到,获得积分10
8秒前
科研通AI6.3的应助被ss采纳,获得10
8秒前
9秒前
廖喜林发布了新的文献求助10
9秒前
忧心的曼凝的应助被Jason采纳,获得10
10秒前
10秒前
10秒前
小苹果完成签到,获得积分10
10秒前
jiao完成签到 ,获得积分10
11秒前
11秒前
朝阳满意完成签到,获得积分10
12秒前
奋斗若风完成签到,获得积分10
13秒前
Juyy完成签到,获得积分10
13秒前
dolphin发布了新的文献求助30
14秒前
lio完成签到,获得积分10
14秒前
xuxu完成签到,获得积分10
14秒前
gaoww完成签到,获得积分10
15秒前
可乐完成签到,获得积分0
15秒前
Max发布了新的文献求助10
16秒前
DD完成签到 ,获得积分10
16秒前
17秒前
阿南完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185632
求助须知:如何正确求助?哪些是违规求助? 9574360
关于积分的说明 21835672
捐赠科研通 7783457
什么是DOI,文献DOI怎么找? 3434643
关于科研通互助平台的介绍 2558998
邀请新用户注册赠送积分活动 2481403